Prior cytomegalovirus reactivation may lead to worse bacterial bloodstream infection outcomes in HSCT patients

CONCLUSIONS: CMV reactivation in BBSI patients is related to higher mortality 1-year after allo-HSCT. Further studies on a larger cohort are needed to better understanding the mechanism of CMV reactivation influence.PMID:38518827 | DOI:10.1016/j.trim.2024.102038

Source: Transplant Immunology - March 22, 2024 Category: Transplant Surgery Authors: Shanshan Li Yang Xiao Mei Jia Source Type: research